First Page | Document Content | |
---|---|---|
Date: 2016-07-13 08:19:06Euphoriants Substituted amphetamines TAAR1 agonists Amphetamine Phenethylamines Stimulant Substance abuse Adderall Prescription drug Adverse effect Dextroamphetamine Controlled substance | Trxuth About Prescription Stimulant Abuse go.osu.edu/generationrxAdd to Reading ListSource URL: pip.missouri.eduDownload Document from Source WebsiteFile Size: 1,08 MBShare Document on Facebook |
Microsoft Word - VLD Packet.FINALDocID: 1rubZ - View Document | |
Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compaDocID: 1rtjz - View Document | |
TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNPDocID: 1rsmr - View Document | |
“Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik AarauDocID: 1rsfZ - View Document | |
Sunil Bhonsle Mar 2015 Corporate PresentationDocID: 1rrwl - View Document |